Abstract:The natural products piperlongumine and piperine have been shown to inhibit cancer cell proliferation through elevation of reactive oxidative species (ROS) and eventually cell death, but only have modest cytotoxic potencies. A series of 14 novel phenylallylidenecyclohexenone analogues based on piperlongumine and piperine therefore were designed and synthesized, and their pharmacological properties were evaluated. Most of the compounds produced antiproliferative activities against five human cancer cells with IC50 values lower than those of piperlongumine and piperine. Among these, compound 9m exerted the most potent antiproliferative activity against drug-resistant Bel-7402/5-FU human liver cancer 5-FU resistant cells (IC50 = 0.8 μM), which was approximately 10-fold lower than piperlongumine (IC50 = 8.4 μM). Further, 9m showed considerably lower cytotoxicity against LO2 human normal liver epithelial cells compared to Bel-7402/5-FU. Mechanistically, compound 9m inhibited thioredoxin reductase (TrxR) activity, increased ROS levels, reduced mitochondrial transmembrane potential (MTP), and induced autophagy in Bel-7402/5-FU cells via regulation of autophagy-related proteins LC3, p62, and beclin-1. Finally, 9m activated significantly the p38 signaling pathways and suppressed the Akt/mTOR signaling pathways. In conclusion, 9m could be a promising candidate for the treatment of drug-resistant cancer cells and, as such, warrants further investigation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00599?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00599</a>.1H NMR and 13C NMR spectra for compounds 9a–n (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00599/suppl_file/np0c00599_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer

Celastrol Suppresses Colorectal Cancer Via Covalent Targeting Peroxiredoxin 1

Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells

Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer

Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy

A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma

Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells

Synthesis of novel oxazol-5-one derivatives containing chiral trifluoromethyl and isoxazole moieties as potent antitumor agents and the mechanism investigation

Design, synthesis, and biological evaluation of novel protopanoxadiol derivatives based PROTACs technology for the treatment of lung cancer

Design and Synthesis of New Hybrids from 2-Cyano-3,12-dioxooleana- 9-Dien-28-oic Acid and O2-(2,4-dinitrophenyl) Diazeniumdiolate for Intervention of Drug-Resistant Lung Cancer.

Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway

Pro-apoptotic effects of JDA-202, a novel natural diterpenoid, on esophageal cancer through targeting peroxiredoxin I.

Design, Synthesis and Antitumor Evaluation of Novel Celastrol Derivatives

Promotion of HeLa Cells Apoptosis by Cynaropicrin Involving Inhibition of Thioredoxin Reductase and Induction of Oxidative Stress

Novel Phenylmethylenecyclohexenone Derivatives As Potent Trxr Inhibitors Display High Antiproliferative Activity And Induce Ros, Apoptosis, And Dna Damage

N‐Phenyl‐2‐Pyridone‐Derived Endoperoxide Suppressing both Lung Cancer and Idiopathic Pulmonary Fibrosis Progression by Three‐Pronged Action

Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities

Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling

Peroxiredoxin 5 protects HepG2 cells from ethyl β-carboline-3-carboxylate-induced cell death via ROS-dependent MAPK signalling pathways

Pristimerin Inhibits Thioredoxin Reductase in the Treatment of Non-Small Cell Lung Cancer

ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance.